2024-11-0920180028-479310.1056/NEJMc18051352-s2.0-85047763925https://hdl.handle.net/20.500.14288/14577N/AMedicineGeneralInternalVenetoclax-rituximab in chronic lymphocytic leukemiaLetter1533-4406433428000020Q13018